Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma 19Lymphoma, Large B-Cell, Diffuse 17Hodgkin Disease 8Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 5Leukemia 5Hemangioma 5Lymphoma, Large-Cell, Anaplastic 4Prostatic Neoplasms 3Neoplasms 3Lymphoma, B-Cell 3Immunoblastic Lymphadenopathy 3Neurotoxicity Syndromes 2Neoplasm, Residual 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Esophageal Stenosis 2Enteropathy-Associated T-Cell Lymphoma 2Vomiting 1Thymoma 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Polycystic Ovary Syndrome 1Philadelphia Chromosome 1Neoplasm Metastasis 1Neoadjuvant Therapy 1Nausea 1

Interventions

pembrolizumab 1pamiparib 1famitinib 1enzalutamide 1apalutamide 1abiraterone 1Prednisone 1Prednisolone 1Poly(ADP-ribose) Polymerase Inhibitors 1Neoadjuvant Therapy 1Folfox protocol 1Fluorouracil 1Drug Therapy 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoadjuvant Therapy × Prednisolone × Clear all
NCT05406999 2022-08-16

Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Recruiting
900 enrolled
Genitourinary

Neoadjuvant Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡